258 related articles for article (PubMed ID: 29807227)
1. Broad targeting of triptolide to resistance and sensitization for cancer therapy.
Hou ZY; Tong XP; Peng YB; Zhang BK; Yan M
Biomed Pharmacother; 2018 Aug; 104():771-780. PubMed ID: 29807227
[TBL] [Abstract][Full Text] [Related]
2. Triptolide and Its Derivatives as Cancer Therapies.
Noel P; Von Hoff DD; Saluja AK; Velagapudi M; Borazanci E; Han H
Trends Pharmacol Sci; 2019 May; 40(5):327-341. PubMed ID: 30975442
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of triptolide-loaded micelles on tumorigenicity inhibition of human ovarian cancer.
Wang Y; Liu T; Li H
J Biomater Sci Polym Ed; 2016; 27(7):545-56. PubMed ID: 26786618
[TBL] [Abstract][Full Text] [Related]
4. LLDT-288, a novel triptolide analogue exhibits potent antitumor activity in vitro and in vivo.
Xu H; Fan X; Zhang G; Liu X; Li Z; Li Y; Jiang B
Biomed Pharmacother; 2017 Sep; 93():1004-1009. PubMed ID: 28724258
[TBL] [Abstract][Full Text] [Related]
5. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer.
Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S
Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407
[TBL] [Abstract][Full Text] [Related]
6. Antagonist effect of triptolide on AKT activation by truncated retinoid X receptor-alpha.
Lu N; Liu J; Liu J; Zhang C; Jiang F; Wu H; Chen L; Zeng W; Cao X; Yan T; Wang G; Zhou H; Lin B; Yan X; Zhang XK; Zeng JZ
PLoS One; 2012; 7(4):e35722. PubMed ID: 22545132
[TBL] [Abstract][Full Text] [Related]
7. Triptolide circumvents drug-resistant effect and enhances 5-fluorouracil antitumor effect on KB cells.
Chen YW; Lin GJ; Chuang YP; Chia WT; Hueng DY; Lin CK; Nieh S; Sytwu HK
Anticancer Drugs; 2010 Jun; 21(5):502-13. PubMed ID: 20154595
[TBL] [Abstract][Full Text] [Related]
8. Increased accumulation of hypoxia-inducible factor-1α with reduced transcriptional activity mediates the antitumor effect of triptolide.
Zhou ZL; Luo ZG; Yu B; Jiang Y; Chen Y; Feng JM; Dai M; Tong LJ; Li Z; Li YC; Ding J; Miao ZH
Mol Cancer; 2010 Oct; 9():268. PubMed ID: 20932347
[TBL] [Abstract][Full Text] [Related]
9. Triptolide induces mitochondria-mediated apoptosis of Burkitt's lymphoma cell via deacetylation of GSK-3β by increased SIRT3 expression.
Kong J; Wang L; Ren L; Yan Y; Cheng Y; Huang Z; Shen F
Toxicol Appl Pharmacol; 2018 Mar; 342():1-13. PubMed ID: 29407771
[TBL] [Abstract][Full Text] [Related]
10. Targeted inhibition of the HNF1A/SHH axis by triptolide overcomes paclitaxel resistance in non-small cell lung cancer.
Li LB; Yang LX; Liu L; Liu FR; Li AH; Zhu YL; Wen H; Xue X; Tian ZX; Sun H; Li PC; Zhao XG
Acta Pharmacol Sin; 2024 May; 45(5):1060-1076. PubMed ID: 38228910
[TBL] [Abstract][Full Text] [Related]
11. [Advance in the anti-tumor mechanism of triptolide].
Luo Y; Shi C; Liao M
Zhongguo Zhong Yao Za Zhi; 2009 Aug; 34(16):2024-6. PubMed ID: 19938536
[TBL] [Abstract][Full Text] [Related]
12. Triptolide and its expanding multiple pharmacological functions.
Liu Q
Int Immunopharmacol; 2011 Mar; 11(3):377-83. PubMed ID: 21255694
[TBL] [Abstract][Full Text] [Related]
13. Triptolide: Medicinal chemistry, chemical biology and clinical progress.
Hou W; Liu B; Xu H
Eur J Med Chem; 2019 Aug; 176():378-392. PubMed ID: 31121546
[TBL] [Abstract][Full Text] [Related]
14. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
[TBL] [Abstract][Full Text] [Related]
15. Enhanced anti-tumor activity of triptolide in combination with irradiation for the treatment of oral cancer.
Chen YW; Lin GJ; Hueng DY; Huang SH; Chia WT; Shieh YS; Ma KH; Sytwu HK
Planta Med; 2014 Mar; 80(4):255-61. PubMed ID: 24510366
[TBL] [Abstract][Full Text] [Related]
16. Triptolide synergistically enhances antitumor activity of oxaliplatin in colon carcinoma in vitro and in vivo.
Liu Y; Xiao E; Yuan L; Li G
DNA Cell Biol; 2014 Jul; 33(7):418-25. PubMed ID: 24720675
[TBL] [Abstract][Full Text] [Related]
17. Herbal compound triptolide synergistically enhanced antitumor activity of vasostatin120-180.
Lin Y; Yang X; Lu M; Zheng W; Zhang J; Zhuang H; Hua ZC
Anticancer Drugs; 2013 Oct; 24(9):945-57. PubMed ID: 23958791
[TBL] [Abstract][Full Text] [Related]
18. Triptolide inhibits cell proliferation and tumorigenicity of human neuroblastoma cells.
Yan X; Ke XX; Zhao H; Huang M; Hu R; Cui H
Mol Med Rep; 2015 Feb; 11(2):791-6. PubMed ID: 25354591
[TBL] [Abstract][Full Text] [Related]
19. Triptolide, A Potential Autophagy Modulator.
Wei YM; Wang YH; Xue HQ; Luan ZH; Liu BW; Ren JH
Chin J Integr Med; 2019 Mar; 25(3):233-240. PubMed ID: 30178091
[TBL] [Abstract][Full Text] [Related]
20. Triptolide Inhibits Lung Cancer Cell Migration, Invasion, and Metastasis.
Reno TA; Kim JY; Raz DJ
Ann Thorac Surg; 2015 Nov; 100(5):1817-24; discussion 1824-5. PubMed ID: 26298168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
